Philadelphia, PA, United States of America

Scott Shandler

This inventor holds 6 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Longevity Biotech, Inc.. Active years: 2017-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott Shandler. Retrieved from https://idiyas.com/inventor/scott-shandler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Scott Shandler: Innovator in Peptide Research

Introduction

Scott Shandler is a prominent inventor based in Philadelphia, PA (US). He has made significant contributions to the field of peptide research, holding a total of 6 patents. His work focuses on developing novel compositions that have the potential to treat various disease states.

Latest Patents

One of Scott Shandler's latest patents is titled "Peptides comprising non-natural amino acids and methods of making and using the same." This invention relates to novel compositions that include analogs of naturally occurring polypeptides. The analogs consist of an α-amino acid and at least one β-amino acid. The administration of these compositions can be utilized for the treatment or prevention of multiple disease states caused by dysfunctional biochemical or biological pathways. The methods and compositions are particularly valuable for identifying new therapeutic modulators of in-vivo receptor activity, which exhibit extended half-lives and relevant bioactivity compared to the naturally translated polypeptides from which the analogs are derived.

Another significant patent by Scott Shandler is "Highly active polypeptides and methods of making and using the same." Similar to his previous work, this invention also involves novel compositions comprising analogs of naturally occurring polypeptides. The focus remains on the potential therapeutic applications of these compositions in addressing various health issues.

Career Highlights

Scott Shandler is currently associated with Longevity Biotech, Inc., where he continues to advance his research in peptide technology. His innovative work has positioned him as a key figure in the biotechnology sector, particularly in the development of therapeutic agents.

Collaborations

Throughout his career, Scott has collaborated with notable professionals in the field, including Samuel Helmer Gellman and John M Gledhill. These collaborations have further enriched his research and contributed to the advancement of peptide science.

Conclusion

Scott Shandler's contributions to peptide research and his innovative patents highlight his role as a leading inventor in the biotechnology field. His work continues to pave the way for new therapeutic solutions that can address complex health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…